- Macrophage lipid metabolism critically regulates immune function and links to the pathogenesis of type 2 diabetes, NAFLD and atherosclerosis.
- Ageing induces distinct alterations in macrophage lipid handling that promote chronic inflammation and metabolic dysfunction, accelerating disease progression.
- Therapeutic modulation of macrophage lipid pathways offers a promising strategy to prevent or treat chronic metabolic diseases.
Sci China Life Sci. 2026 Nov 9. doi: 10.1007/s11427-026-3490-5. Online ahead of print.
ABSTRACT
Chronic metabolic diseases, such as type 2 diabetes, non-alcoholic fatty liver disease (NAFLD) and atherosclerosis, constitute a major burden on global health. The pathogenesis of these diseases is closely related to immune-metabolic disorders. Immunometabolism refers to the changes in intracellular metabolic pathways within immune cells that alter their functions. The lipid metabolism of macrophages is an important aspect of immunometabolism. Macrophages play a crucial role in tissue homeostasis and inflammatory responses through their plasticity. Aging macrophages show distinct lipid metabolic characteristics in comparison with young cells, which may be associated with the progression of chronic metabolic diseases. This article aims to explore how normal and aging macrophages affect the occurrence and development of chronic metabolic diseases.
PMID:43033333 | DOI:10.1007/s11427-026-3490-5
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

